Depressed glutamate transporter 1 expression in a mouse model of Dravet syndrome
Annals of Clinical and Translational Neurology · 2023
DOI: 10.1002/acn3.51851 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2023. Verfasst von Mustafa Q Hameed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neuromodulation Program, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Epilepsies, Myoclonic, Epilepsy, Excitatory Amino Acid Transporter 2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Dravet syndrome (DS) is a monogenic, often refractory, epilepsy resultant from SCN1A haploinsufficiency in humans. A novel therapeutic target in DS that can be engaged in isolation or as adjunctive therapy is highly desirable. Here, we demonstrate reduced expression of the rodent glutamate transporter type 1 (GLT‐1) in a DS mouse model, and in wild type mouse strains where Scn1a haploinsufficiency is most likely to cause epilepsy, indicating that GLT‐1 depression may play a role in DS seizures. As GLT‐1 can be upregulated by common and safe FDA‐approved medications, this strategy may be an attractive, viable, and novel avenue for DS treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neuromodulation Program, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- FM Kirby Neurobiology Center, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Mustafa Q Hameed, Sheryl Anne D Vermudez, Alexander Rotenberg
Förderung
- NICHD NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Hameed, M. Q., Hui, B., Lin, R., MacMullin, P. C., Pascual-Leone, A., Vermudez, S. A. D., & Rotenberg, A. (2023). Depressed glutamate transporter 1 expression in a mouse model of Dravet syndrome. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.51851
Vancouver
Hameed MQ, Hui B, Lin R, MacMullin PC, Pascual-Leone A, Vermudez SAD, et al. Depressed glutamate transporter 1 expression in a mouse model of Dravet syndrome. Annals of Clinical and Translational Neurology. 2023. doi:10.1002/acn3.51851
BibTeX
@article{Hameed2023,
author = {Hameed, Mustafa Q and Hui, Benjamin and Lin, Rui and MacMullin, Paul C and Pascual-Leone, Andres and Vermudez, Sheryl Anne D and Rotenberg, Alexander},
title = {Depressed glutamate transporter 1 expression in a mouse model of Dravet syndrome},
journal = {Annals of Clinical and Translational Neurology},
year = {2023},
doi = {10.1002/acn3.51851}
}
EUVIMED